Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-21-022463
Filing Date
2021-03-22
Accepted
2021-03-22 20:33:52
Documents
1
Period of Report
2021-03-18

Document Format Files

Seq Description Document Type Size
1 FORM 3/A SUBMISSION doc3a.html 3/A  
1 FORM 3/A SUBMISSION doc3a.xml 3/A 6190
  Complete submission text file 0001209191-21-022463.txt   7560
Mailing Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219
Business Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219 (972) 499-3350
Instil Bio, Inc. (Issuer) CIK: 0001789769 (see all company filings)

EIN.: 832072195 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O INSTIL BIO, INC. 3963 MAPLE AVENUE, SUITE 350 DALLAS TX 75219
Business Address
Crouch Bronson (Reporting) CIK: 0001851041 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-40215 | Film No.: 21762778